Photo from wikipedia
A phase I trial of the FGFR inhibitor rogaratinib showed safety and efficacy in advanced cancers. Click to show full abstract
A phase I trial of the FGFR inhibitor rogaratinib showed safety and efficacy in advanced cancers.
Keywords:
safety preliminary;
efficacy shown;
efficacy;
evidence efficacy;
preliminary evidence;
safety
Journal Title: Cancer discovery
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cancer discovery
Year Published: 2019
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!